Member Info for bobbust

The £20k is a buy

Standared fair from Motley fool.

They highlight the positives but in the end say they would not invest as they are not making money.

When Scancell go up they can cut and paste the positive bits and not mention the last line.

To be a good investor you need to look a bit deeper and make an informed desicion on risk.

Mouse trials, SCIB1 trials and early Modi 1 results increase the chance of success and reduce the risk.

I for one have kept buying after recent news

They never really committee one way or the other.
If they go up they will point out they talked about it.
If it goes down they will say we never said buy.
It's the same every article

Krafty you are right about tomorrow.
I guess they would rather wait and do one RNS with results for all 3 after the follow up scan Trish has just had.
But you would think that they have to say something.
Might say " confirm recent speculation that patient 1 tumor has continued to shrink "
More detailed update to follow in due course

Made more money in a day on Scancell before but today is different.
Real tumor shrinkage.
Amazing

That made me laugh out load.
" No reason other than on the verge of curing cancer"

At the end of the day we may make a few quid but the really important thing is Trish was heading for palliative treatment now she could be on the way to be cured.
Hopefully the 1st of many

Shares should drop around Christmas day if they stick to the 9 months.
I wonder if we will get an update before

They could be today or next week we just don't know.
Positive results should move the SP up.
Mainstream media coverage could add a big boost.
Big Pharma may show more interest but won't move until there is further data.
Linda won't sell it unless it's a huge amount and results are to early for them to spend that amount of cash

The board know Trish is posting on her blog and several share holders are following her blog.
Because of this I would expect a Modi 1 update very soon.
It's been a month since she 1st posted so I am guessing that the other 2 have had a least one scan.
Plus Cohort 3 may have had 1st jab?

Read her post but dont go on there and ask her questions.
That is a site for those, or there family, with cancer.
we have been hear for 10 years plus.
A few days/ weeks more is not a lot to ask.

It looks like from her post 12 days ago that her hearing has improved further from the initial post

they have asked if Cohort 1 can be moved to full dose but as of the AGM had not yet had approval

After the poor SP response to recent RNS's I am not surprised by this tick up.
A re-rate to a higher level is justified based on the company now de-risked to an extent.
The end point is just as high as ever but now we have a revenue generating deal.
Modi 1 progressing and indicated success.

So what has been suggested is they sold 11m last month.
11m this month and another 11m in the new year.
Not a huge amount given the recent daily volumes.
Remember they can only sell once

Trish is due for another scan in a week. If she has made progress and writes about it on her blog we may get an RNS ain a couple of weeks

All good news.
Covid results early in the new year.
Modi 1 recruitment progressing well.
Early results better than expected
iSCIB1+ doubles survival.
Lots of talk of other deals.
The Glymabs we are keeping looks amazing

Good volume today give it's not even 9am

This one is Avidimab.
Next deal if you ask me.

Remember this is why Redmile invested in Scancell

Is this GRP78 antibody new?